Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.51 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.50 |
| ▸ | IDO1 | P14902 | 2/20 | 0.45 |
| ▸ | AGXT | P21549 | 2/20 | 0.45 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.42 |
| ▸ | CMA1 | P23946 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL545138 | 0.87 | MAPK1 (0.40) | TAAR1CHRM2CHRM1CHRM3 | |
| SCHEMBL544056 | 0.83 | CYP4F2 (0.51) | — | |
| 2-Ethylhexanoic Acid SCHEMBL6235255 | 0.81 | CTSK (0.42) | CHRM2CHRM1CHRM3 | |
| Emilium SCHEMBL29388187 | 0.79 | CHRM2 (0.53) | TAAR1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL26858767 | 0.79 | TAAR1 (0.59) | TAAR1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL9248085 | 0.78 | TSHR (0.53) | TAAR1CHRM2CHRM1CHRM3IDO1 | |
| Hydrochloric Acid SCHEMBL11518426 | 0.78 | ELANE (0.36) | — | |
| SCHEMBL9071087 | 0.77 | TAAR1 (0.71) | TAAR1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL29365903 | 0.77 | TAAR1 (0.71) | TAAR1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL2427142 | 0.77 | TAAR1 (0.71) | TAAR1CHRM2CHRM1CHRM3IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110707-B2 | Surfactant | AISIN AW CO., LTD. (JP) | 2012-02-07 | — | — | US | disclosed |
| US-20100191014-A1 | SURFACTANT | AISIN AW CO., LTD (JP) | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100191014-A1 | SURFACTANT | SLC27A1, LIPA, ABHD16A | TAAR1 1228/4885CHRM2 896/4885CHRM1 987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.